Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, ...

Start by commissioning every business unit to identify the top GenAI use cases that address pain points within their unit and ...

Hewlett Packard Enterprise used its 2025 analyst meeting to argue it is entering a new phase of profitable growth, driven by ...

Ventus Therapeutics, a clinical-stage biopharmaceutical company advancing two Phase 2 small-molecule programs for ...

The authors argue that AI is the structural enabler of this paradigm shift. It combines machine learning, big data, the ...

Good morning. Welcome to T-Mobile's Third Quarter 2025 Earnings Call. Joining me on our call today are Mike Sievert, our President and CEO; Srini Gopalan, our COO and incoming CEO; Peter Osvaldik, our ...

Ericsson will be Vodafone’s sole radio access network (RAN) vendor nationwide across Ireland, Netherlands, and Portugal, ...

Nancy Avila had retired from operational roles. Then the opportunity to lead technology in the AI age at a semiconductor firm ...

Take your investment strategy to the next level. Learn how a resilient portfolio can help limit your losses in a downturn, ...

MMM is only as good as its data and assumptions. Avoid common modeling pitfalls and turn your analysis into real business ...

Ventus Therapeutics enters agreement with Genentech to discover and develop small-molecule medicines using Ventus’ ReSOLVE platform: Waltham, Massachusetts Thursday, October 23, ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...